Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
1
7
3
0
0
CIDARA THERAPEUTICSCS INC Acción · US1717571079 · CDTX · A14R2R (XNMS) — cotizaciones en tiempo real, datos de la empresa, dividendos, fundamentales y análisis de cartera con IA en MoneyPeak
Análisis impulsado por IA
Análisis fundamental
Descubre lo que realmente dicen los números — antes que el mercado
Analizar ahora
Sentimiento de noticias
¿Las noticias de hoy son una señal de compra o una alerta?
Analizar ahora
Comprar / Mantener / Vender
¿Comprar, mantener o vender? Obtén el veredicto de la IA ahora.
Analizar ahora
Evaluación de riesgos
Descubre riesgos ocultos antes de que afecten a tu cartera.
Analizar ahora
Valor justo
¿Esta acción está barata, correctamente valorada o sobrevalorada?
Analizar ahora
Latest AI Analyses of CIDARA THERAPEUTICSCS INC
Analyst Grade Summary
No Price
Share Float & Liquidity
Free Float 76,40 %
Shares Float 19,37 M
Shares Outstanding 25,36 M
Company Profile for CIDARA THERAPEUTICSCS INC Share
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also advances its Cloudbreak platform to develop conjugates for the prevention and treatment of influenza and other viral infections, such as RSV, HIV, and the SARS-CoV-2 strains causing COVID-19. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California.
Company Data
Name CIDARA THERAPEUTICSCS INC
Company Cidara Therapeutics, Inc.
Symbol CDTX
Website
https://www.cidara.com
Primary Exchange 
NASDAQ/NMS (GLOBAL MARKET)
NASDAQ/NMS (GLOBAL MARKET)
WKN A14R2R
ISIN US1717571079
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Jeffrey L. Stein
Market Capitalization 6 Mrd.
Country United States of America
Currency USD
Employees 0,0 T
Address 6310 Nancy Ridge Drive, 92121 San Diego
IPO Date 2015-04-15
Stock Splits
| Date | Split |
|---|---|
| 24.04.2024 | 1:20 |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | CDTX |
More Shares
Investors who hold CIDARA THERAPEUTICSCS INC also have the following shares in their portfolio:
